The Board of Directors and Management

Mats Rönngard


Born 1956. Grew up in an entrepreneurial family and studied economics at Lund University. Mats is an entrepreneur with more than 30 years of experience in helping numerous international listed companies, primarily in fast-moving consumer products and pharmaceuticals, with their marketing and sales. His list of customers include companies such as Swedish Match, Carlsberg, Kraft Foods, AstraZeneca, and Novo Nordisk.

Phone: + 46 (0) 708 728 250

Annette Agerskov


Born 1960. Solid work experience with nicotine substitutes in general and with nicotine gum in particular. For most of her career, Annette has held senior positions in Fertin Pharma A / S, one of the world's largest nicotine gum manufacturers. Annette's many years in the nicotine substitute industry has generated a broad network of contacts with both suppliers and retailers. Annette has a Master's Degree in Marketing and International Business from Aarhus Business School.

Phone: +45 (0) 20 60 79 16

Anders Ermén


Born 1963. Own business since 1996, specialising in accounting, business development, and management. Anders has over 20 years of experience in the music and media industry, both nationally and internationally, as well as experience in the pharmaceutical industry. Anders also has extensive experience in tax issues and contract negotiations.

Tomas Eriksson


Born 1964. CEO at Sinntaxis that develops pharmaceuticals for brain rehabilitation of stroke patients. Co-founder and former CEO of A1M Pharma, a drug development company that focuses on treatment for acute kidney damage. Tomas has a Bachelor of Science degree from Lund University with a main focus of business economics. Tomas has vast experience of working in senior positions in medical technology and diagnostics, such as: Area Manager Gambro AB, Sales Manager Nordic Bioscience (Denmark) and Sales & Marketing Director in Magle Life Science AB.

Mats Persson


Born 1961. CEO of Hamlet Pharma, which conducts drug development with an aim of developing new pharmaceuticals for cancer treatment. Over several years, Mats has held senior positions at companies such as LEO Pharma in Denmark, where Mats was part of the research and development management team. Mats has a PhD in biochemistry and has more than 20 years of experience in clinical research and development from AstraZeneca.

Anders Jungbeck


Born 1955. Anders has a background in the pharmaceutical industry, with senior positions in companies such as Astra Zeneca, GSK, Ratiopharm and Actavis. Anders has board assignments in Omet AB and Byggnadsbolaget Qbostaden and has previously served in the board of Enzymatica. Anders has worked both in Sweden and abroad and has extensive experience of business development and global launches.